Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

28491 - 28500 of 44979 results found

Optimizing the use of vilobelimab for the treatment of COVID-19

Date
Saturday, July 08, 2023 - 4:00 AM
Description
INTRODUCTION: On 4 April 2023, the United States Food and Drug Administration issued an emergency use authorization for the use of vilobelimab (Gohibic^(TM)) for the treatment of COVID-19 in hospitalized adults when initiated within 48 hours of

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry

Date
Saturday, July 08, 2023 - 4:00 AM
Description
SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal transmembrane protein, can serve as an alternative receptor for SARS